Income Taxes |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Income Tax Disclosure [Abstract] | |
| Income Taxes | Income Taxes The income tax expense for the three months ended June 30, 2026 and June 30, 2025 was $0.1 million and $0.2 million, respectively. The income tax expense for the six months ended June 30, 2026 and June 30, 2025 was $0.3 million and $0.3 million, respectively. The income tax expense was determined based upon estimates of the Company’s effective income tax rates in various jurisdictions. The difference between the Company’s effective income tax rate and the U.S. federal statutory rate is primarily attributable to state income taxes, foreign income taxes, and non-recognition of US tax benefit because of a full valuation allowance against US deferred tax assets. The income tax expense for the six months ended June 30, 2026 and June 30, 2025 relates primarily to state minimum income tax and income tax on the Company’s earnings in foreign jurisdictions. On July 4, 2025, the One Big Beautiful Bill Act (the “Act”) was signed into law. The Act contains significant tax law changes with various effective dates after its enactment date. The Company has evaluated the impact of the Act as part of its income tax provision for the six months ended June 30, 2026. Given the Company’s current loss position and the full valuation allowance recorded against its deferred tax assets, the enactment of the Act did not have a material impact on the Company’s condensed consolidated financial statements.
|